LumaBio I LP — Form D/A
LumaBio I LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-06. $107.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-06
- Form: D/A
- Accession: 0001981267-25-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $107.2M
- Investors: 25
- Date of first sale: 2023-07-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-487584
Issuer
- Name: LumaBio I LP
- CIK: 0001981267
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: 595 Madison Avenue, 31st Floor, NEW YORK, NY, 10022
- Phone: 917-859-9186
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Joshua Fink | Executive Officer | New York, NY |
| Themasap Khan | Executive Officer | Redwood City, CA |
| William Ryan | Executive Officer | New York, NY |
| Joshua Fink | Promoter | New York, NY |
| Themasap Khan | Promoter | Redwood City, CA |
| N/A Luma Group Advisor LLC | Promoter | New York, NY |
| N/A Luma Group GP Holdings LP | Promoter | Grand Cayman, E9 |
| N/A Luma Group TopCo LLC | Promoter | Grand Cayman, E9 |
Other filings by this issuer (2)
More